Misdiagnosis of ligamentoid fibromatosis of the small mesenteric: A case report

被引:1
作者
Xu, Kai [1 ]
Zhao, Qi-Kang [1 ]
Liu, Jing-Shan [1 ]
Zhou, Dong-Hai [1 ]
Chen, Yong-Liang [2 ]
Zhu, Xing-Yi [1 ]
Su, Ming [2 ]
Huang, Kun-Quan [1 ]
Du, Wen [1 ]
Zhao, Hong-Yu [1 ]
机构
[1] Peking Univ, Shougang Hosp, Dept Gen Surg, 9 Jinyuangzhuang Rd, Beijing 100041, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing 100853, Peoples R China
关键词
Ligamentoid fibromatosis; Borderline tumor; Pathology; Surgery; Combined treatment; Small mesenteric; Case report; AGGRESSIVE FIBROMATOSIS; DESMOID TUMORS; MANAGEMENT; IMATINIB; THERAPY;
D O I
10.12998/wjcc.v8.i22.5758
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Ligamentoid fibromatosis is a rare borderline tumor that occurs in the muscles, fascia, and aponeurosis. It is a kind of soft tissue tumor of fibrous origin, also known as invasive fibromatosis, desmoid fibroma, neurofibromatosis, etc. The tumor is between benign and malignant tumors and rarely has distant metastasis. Its characteristics are mainly local invasion, destruction and growth and easy recurrence. The World Health Organization defines it as a fibroblast cloning value-added lesion originating from deep soft tissue, which causes local invasion and growth leading to tissue reconstruction, extrusion and destruction of important structures and organs. The incidence rate accounts for 0.03% of all tumors and less than 3% of all soft tissue tumors. Definite diagnosis mainly depends on postoperative pathology. Surgical resection is still the main way to treat the disease, and a variety of nonsurgical treatment methods are auxiliary. Combined treatment can effectively reduce the risk of postoperative recurrence. CASE SUMMARY The patient is a 57-year-old female. One week ago, she accidentally found a mass in the left upper abdomen while lying flat. There was no abdominal pain and abdominal distention, no fever, no black stool and blood in the stool and no nausea and vomiting. She had a 10-year history of glaucoma on the left side, underwent hysterectomy for uterine fibroids 5 years ago, had no hypertension, heart disease, diabetes, hepatitis or tuberculosis, had no history of smoking and had been drinking for 20 years. CONCLUSION Accurate preoperative diagnosis is difficult, surgical resection is the main treatment, and a variety of nonsurgical treatment methods are auxiliary. Combined treatment can effectively reduce the risk of postoperative recurrence. The prognosis is still good, and the risk of recurrence of secondary surgery is greatly increased.
引用
收藏
页码:5758 / 5764
页数:7
相关论文
共 28 条
  • [1] Nuclear β-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions
    Bhattacharya, B
    Dilworth, HP
    Iacobuzio-Donahue, C
    Ricci, F
    Weber, K
    Furlong, MA
    Fisher, C
    Montgomery, E
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (05) : 653 - 659
  • [2] Pediatric aggressive fibromatosis - A retrospective analysis of 13 patients and review of the literature
    Buitendijk, S
    van de Ven, CP
    Dumans, TG
    den Hollander, JC
    Nowak, PJ
    Tissing, WJ
    Pieters, R
    van den Heuvel-Eibrink, MM
    [J]. CANCER, 2005, 104 (05) : 1090 - 1099
  • [3] Successful treatment of recurrent pelvic desmoid tumour with tamoxifen
    Chao, AS
    Lai, CH
    Hsueh, S
    Chen, CS
    Yang, YC
    Soong, YK
    [J]. HUMAN REPRODUCTION, 2000, 15 (02) : 311 - 313
  • [4] Mesenteric Fibromatosis Causing Ureteral Stenosis
    Choi, Jae Young
    Kang, Kyung Mo
    Kim, Bum Soo
    Kim, Tae-Hwan
    [J]. KOREAN JOURNAL OF UROLOGY, 2010, 51 (07) : 501 - 504
  • [5] Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial
    Chugh, Rashmi
    Wathen, J. Kyle
    Patel, Shreyaskumar R.
    Maki, Robert G.
    Meyers, Paul A.
    Schuetze, Scott M.
    Priebat, Dennis A.
    Thomas, Dafydd G.
    Jacobson, Jon A.
    Samuels, Brian L.
    Benjamin, Robert S.
    Baker, Laurence H.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (19) : 4884 - 4891
  • [6] Desmoid tumors of the head and neck: A therapeutic challenge
    de Bree, Eelco
    Zoras, Odysseas
    Hunt, Jennifer L.
    Takes, Robert P.
    Suarez, Carlos
    Mendenhall, William M.
    Hinni, Michael L.
    Rodrigo, Juan P.
    Shaha, Ashok R.
    Rinaldo, Alessandra
    Ferlito, Alfio
    de Bree, Remco
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (10): : 1517 - 1526
  • [7] The management of extra-abdominal desmoid tumours
    Duggal, A
    Dickinson, IC
    Sommerville, S
    Gallie, P
    [J]. INTERNATIONAL ORTHOPAEDICS, 2004, 28 (04) : 252 - 256
  • [8] Desmoid tumor of the small bowel and the mesentery
    Faria, SC
    Iyer, RB
    Rashid, A
    Ellis, L
    Whitman, GJ
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (01) : 118 - 118
  • [9] Aggressive fibromatosis
    Fisher, Cyril
    Thway, Khin
    [J]. PATHOLOGY, 2014, 46 (02) : 135 - 140
  • [10] High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors
    Hansmann, A
    Adolph, C
    Vogel, T
    Unger, A
    Moeslein, G
    [J]. CANCER, 2004, 100 (03) : 612 - 620